# Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion

> **NCT05291403** · NA · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 141 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** Medical thoracoscopic cryotherapy combined with standard first-line therapy for advanced non-cell lung cancer
- **OTHER:** Sequential intrathoracic injection of cisplatin/erythromycin combined with standard first-line therapy for advanced non-cell lung cancer
- **OTHER:** Standard first-line therapy for advanced non-cell lung cancer without intrathoracic treatment

## Key facts

- **NCT ID:** NCT05291403
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-06
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 141 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05291403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05291403, "Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05291403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*